Hikma Pharmaceuticals
-4.0%

Pharma / Pharmaceuticals and Generic Medicines

Info

Overview Core Facts Blog Ratings Executives My Comments

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Risks

1. Regulatory Risk: The company is subject to regulations by various health authorities worldwide in relation to the manufacturing, marketing and selling of its products. Any changes or delays in obtaining regulatory approval may have a negative effect on the company’s financial performance.

2. Drug Development Risk: The company is heavily dependent on the development of new drugs and products. If these products fail to reach the market, then Hikma’s products will become less competitive and its revenue will suffer.

3. Price Risk: The company’s product pricing is subject to various conditions including competition, government regulation, market conditions, and economic conditions. Changes in these conditions could result in decreased pricing of its products, resulting in decreased revenue.

4. Currency Risk: A large portion of Hikma’s revenue comes from outside the USA. Changes in foreign currency exchange rates can significantly impact its revenues.

5. Political Risk: The company is subject to political and economic uncertainty in its various international markets, which could negatively affect its revenue.

6. Competition Risk: The industry is highly competitive and Hikma faces numerous highly experienced and well-funded competitors. If Hikma is unable to compete effectively, its revenues could suffer.

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.